Consistent with these mechanistic insights, TIGIT has been linked to poor prognosis in cervical cancer (CC) [78], highlighting its potential role in mediating immune evasion and disease progression in this malignancy. This evidence concerns the gene TIGIT and cholangiocarcinoma.